These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28603087)

  • 1. Cysteine-rich whey protein isolate (Immunocal®) ameliorates deficits in the GFAP.HMOX1 mouse model of schizophrenia.
    Song W; Tavitian A; Cressatti M; Galindez C; Liberman A; Schipper HM
    Free Radic Biol Med; 2017 Sep; 110():162-175. PubMed ID: 28603087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cysteine-rich whey protein supplement, Immunocal®, preserves brain glutathione and improves cognitive, motor, and histopathological indices of traumatic brain injury in a mouse model of controlled cortical impact.
    Ignowski E; Winter AN; Duval N; Fleming H; Wallace T; Manning E; Koza L; Huber K; Serkova NJ; Linseman DA
    Free Radic Biol Med; 2018 Aug; 124():328-341. PubMed ID: 29940352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cysteine-rich whey protein (immunocal®) supplementation in combination with resistance training on muscle strength and lean body mass in non-frail elderly subjects: a randomized, double-blind controlled study.
    Karelis AD; Messier V; Suppère C; Briand P; Rabasa-Lhoret R
    J Nutr Health Aging; 2015 May; 19(5):531-6. PubMed ID: 25923482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinsonian features in aging GFAP.HMOX1 transgenic mice overexpressing human HO-1 in the astroglial compartment.
    Song W; Cressatti M; Zukor H; Liberman A; Galindez C; Schipper HM
    Neurobiol Aging; 2017 Oct; 58():163-179. PubMed ID: 28746897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Craniofacial anomalies in schizophrenia-relevant GFAP.HMOX1
    Tavitian A; Somech J; Chamlian B; Liberman A; Galindez C; Schipper HM
    Anat Rec (Hoboken); 2024 Nov; 307(11):3529-3547. PubMed ID: 38606671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Cystine-Rich Whey Supplement (Immunocal®) Provides Neuroprotection from Diverse Oxidative Stress-Inducing Agents
    Winter AN; Ross EK; Daliparthi V; Sumner WA; Kirchhof DM; Manning E; Wilkins HM; Linseman DA
    Oxid Med Cell Longev; 2017; 2017():3103272. PubMed ID: 28894506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schizophrenia-like features in transgenic mice overexpressing human HO-1 in the astrocytic compartment.
    Song W; Zukor H; Lin SH; Hascalovici J; Liberman A; Tavitian A; Mui J; Vali H; Tong XK; Bhardwaj SK; Srivastava LK; Hamel E; Schipper HM
    J Neurosci; 2012 Aug; 32(32):10841-53. PubMed ID: 22875919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral supplementation with whey proteins increases plasma glutathione levels of HIV-infected patients.
    Micke P; Beeh KM; Schlaak JF; Buhl R
    Eur J Clin Invest; 2001 Feb; 31(2):171-8. PubMed ID: 11168457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Cystine-Rich Whey Supplement (Immunocal(®)) Delays Disease Onset and Prevents Spinal Cord Glutathione Depletion in the hSOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis.
    Ross EK; Winter AN; Wilkins HM; Sumner WA; Duval N; Patterson D; Linseman DA
    Antioxidants (Basel); 2014 Dec; 3(4):843-65. PubMed ID: 26785244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocal® limits gliosis in mouse models of repetitive mild-moderate traumatic brain injury.
    Koza LA; Pena C; Russell M; Smith AC; Molnar J; Devine M; Serkova NJ; Linseman DA
    Brain Res; 2023 Jun; 1808():148338. PubMed ID: 36966959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open-labeled pilot study of cysteine-rich whey protein isolate supplementation for nonalcoholic steatohepatitis patients.
    Chitapanarux T; Tienboon P; Pojchamarnwiputh S; Leelarungrayub D
    J Gastroenterol Hepatol; 2009 Jun; 24(6):1045-50. PubMed ID: 19638084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term supplementation with whey proteins on plasma glutathione levels of HIV-infected patients.
    Micke P; Beeh KM; Buhl R
    Eur J Nutr; 2002 Feb; 41(1):12-8. PubMed ID: 11990003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural HO-1/sterol interactions in vivo: implications for Alzheimer's disease.
    Hascalovici JR; Song W; Liberman A; Vaya J; Khatib S; Holcroft C; Laferla F; Schipper HM
    Neuroscience; 2014 Nov; 280():40-9. PubMed ID: 25218961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocal® and preservation of glutathione as a novel neuroprotective strategy for degenerative disorders of the nervous system.
    Ross EK; Gray JJ; Winter AN; Linseman DA
    Recent Pat CNS Drug Discov; 2012 Dec; 7(3):230-5. PubMed ID: 22742422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label dose-response study of lymphocyte glutathione levels in healthy men and women receiving pressurized whey protein isolate supplements.
    Zavorsky GS; Kubow S; Grey V; Riverin V; Lands LC
    Int J Food Sci Nutr; 2007 Sep; 58(6):429-36. PubMed ID: 17710587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astrocyte heme oxygenase-1 reduces mortality and improves outcome after collagenase-induced intracerebral hemorrhage.
    Chen-Roetling J; Kamalapathy P; Cao Y; Song W; Schipper HM; Regan RF
    Neurobiol Dis; 2017 Jun; 102():140-146. PubMed ID: 28323022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of supplementation with a cysteine donor on muscular performance.
    Lands LC; Grey VL; Smountas AA
    J Appl Physiol (1985); 1999 Oct; 87(4):1381-5. PubMed ID: 10517767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the astrocytic Nrf2/ARE system ameliorates the formation of demyelinating lesions in a multiple sclerosis animal model.
    Draheim T; Liessem A; Scheld M; Wilms F; Weißflog M; Denecke B; Kensler TW; Zendedel A; Beyer C; Kipp M; Wruck CJ; Fragoulis A; Clarner T
    Glia; 2016 Dec; 64(12):2219-2230. PubMed ID: 27641725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial HMOX1 expression promotes central and peripheral α-synuclein dysregulation and pathogenicity in parkinsonian mice.
    Cressatti M; Song W; Turk AZ; Garabed LR; Benchaya JA; Galindez C; Liberman A; Schipper HM
    Glia; 2019 Sep; 67(9):1730-1744. PubMed ID: 31180611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sinister face of heme oxygenase-1 in brain aging and disease.
    Schipper HM; Song W; Tavitian A; Cressatti M
    Prog Neurobiol; 2019 Jan; 172():40-70. PubMed ID: 30009872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.